Deerfield Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
DTC
BC
B
FLSM
GPP
Deerfield Management's ANAB Position: Q3 2023 in Review
Deerfield Management sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 613,000 shares — an estimated $12.5M sold.
Deerfield Management first reported a position in ANAB in Q1 2017 and held it in 16 quarters. The position peaked at $82.7M in Q1 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.
- Deerfield Management reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
- Deerfield Management sold 613,000 AnaptysBio shares in Q3 2023, an estimated $12.5M.
- Deerfield Management first reported a position in AnaptysBio in Q1 2017 and held it in 16 quarters.
- Deerfield Management's AnaptysBio position peaked at $82.7M in Q1 2018.
- 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.
Based on Deerfield Management's 13F filing for Q3 2023, filed 14 Nov 2023.